Therapeutic Potential of MRGPRX2 Inhibitors on Mast Cells
Mast cells (MCs) act as primary effectors in inflammatory and allergic reactions by releasing intracellularly-stored inflammatory mediators in diseases. The two major pathways for MC activation are known to be immunoglobulin E (IgE)-dependent and -independent. Although IgE-dependent signaling is the...
Enregistré dans:
Auteurs principaux: | , |
---|---|
Format: | article |
Langue: | EN |
Publié: |
MDPI AG
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/2ea13677bbc942228470c48136bd7146 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|